Skip to main content
. 2016 May 17;8(12):18712–18725. doi: 10.18632/oncotarget.9409

Figure 2. Expression of SERPINA3 in melanoma biopsies grouped according to various clinicopathologic paramaters.

Figure 2

Scoring scale: Low=0-4; High=5-12. Panel A. SERPINA3 expression grouped by AJCC stages. Panel B. SERPINA3 expression grouped by gender. Panel C. SERPINA3 expression grouped by melanoma thickness. Panel D. SERPINA3 expression grouped by ulceration status.